Related Experiment Video
Updated: Apr 16, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy - a cardiac magnetic resonance
Soraya El Ghannudi1, Anthony Nghiem2, Philippe Germain3
1Radiology Department, University Hospital of Strasbourg, Strasbourg, France. ; Nuclear Medicine Department, University Hospital of Strasbourg, Strasbourg, France.
Insights
Left ventricular involvement in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is common, affecting over half of patients. This condition often presents with significant right ventricular abnormalities, warranting further study into its prognostic implications.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) primarily affects the right ventricle.
- Left ventricular (LV) involvement in ARVD/C is understudied.
- Understanding LV involvement is crucial for comprehensive ARVD/C diagnosis and management.
Purpose of the Study:
- To determine the frequency of LV involvement in ARVD/C.
- To describe the clinical presentation of LV involvement in ARVD/C.
- To characterize the pattern of LV abnormalities in ARVD/C patients.
Main Methods:
- Retrospective analysis of cardiac magnetic resonance (CMR) data from 202 patients.
- Diagnosis of ARVD/C based on the 2010 revised task force criteria.
- Evaluation of LV parameters including LVEDV, LVEF, LVLE, and WMAs.
Main Results:
- 21 patients diagnosed with ARVD/C; 52.4% exhibited LV involvement (LV-ARVD/C).
- LV abnormalities significantly correlated with right ventricular (RV) dysfunction and late gadolinium enhancement (RVLE).
- LV late enhancement (LVLE) was strongly associated with LV WMAs, reduced LVEF, and increased LVEDV.
Conclusions:
- Left ventricular involvement is a common finding in ARVD/C.
- LV-ARVD/C is frequently accompanied by moderate to severe RV abnormalities.
- The prognostic impact of LV involvement in ARVD/C requires further investigation.
Background:
Few studies evaluated left ventricular (LV) involvement in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). The aim of this study is to determine the frequency, clinical presentation, and pattern of LV involvement in ARVD/C (LV-ARVD/C).
Methods:
We retrospectively evaluated the cardiac magnetic resonance (CMR) in 202 patients referred between 2008 and 2012 to our institution, and we determined the presence or the absence of CMR criteria in the revised task force criteria 2010 for the diagnosis of ARVD/C. A total of 21 patients were diagnosed with ARVD/C according to the revised task force criteria 2010. All included patients had no previous history of myocarditis, acute coronary syndrome, or any other cardiac disease that could interfere with the interpretations of structural abnormalities. The LV involvement in ARVD/C was defined by the presence of one or more of the following criteria: LV end-diastolic volume (LVEDV; >95 mL/m(2)), LV ejection fraction (LVEF; <55%), LV late enhancement of gadolinium (LVLE) in a non-ischemic pattern, and LV wall motion abnormalities (WMAs). In the follow-up for the occurrence of cardiac death, ventricular tachycardia (VT) was obtained at a mean of 31 ± 20.6 months.
Results:
A total of 21 patients had ARVD/C. The median age was 48 (33-63) years. In all, 11 patients (52.4%) had LV-ARVD/C. The demographic characteristics of patients with or without LV were similar. There was a higher frequency of left bundle-branch block (LBBB) VT morphology in ARVD/C (P = 0.04). In CMR, regional WMAs of right ventricle (RV) and RV ejection fraction (RVEF; <45%) were strongly correlated with LV-WMAs (r = 0.72, P = 0.02, r = 0.75, P = 0.02, respectively). RV late enhancement of gadolinium (RVLE) was associated with LV-WMs and LVLE (r = 0.7, P = 0.03; r = 0.8, P = 0.006). LVLE was associated with LV-WMAs, LVEF, and LVEDV (r = 0.9, P = 0.001; r = 0.8, P = 0.001; r = 0.8, P = 0.01).
Conclusion:
LV involvement in ARVD/C is common and frequently associated with moderate to severe right ventricular (RV) abnormalities. The impact of LV involvement in ARVD/C on the prognosis needs further investigations.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
07:11Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests